2026-11-06
Nature Study Reveals the Molecular Mechanism by Which Mild Cold Extends Lifespan
Moderate cold exposure can extend lifespan across many species — a phenomenon observed and recorded for over a century, yet its molecular mechanism has remained unclear. Recently, a team led by David Vilchez and Christian Frezza at the University of Cologne published a study in Nature, reporting a metabolite-mediated, multi-tissue signaling pathway that links cold temperature to both lifespan extension and the maintenance of protein homeostasis.
2026-11-06
A Human First! Gene-Editing Technology Directly Rewrites DNA Inside the Body
A powerful gene-editing technology has been used to edit DNA directly inside the human body — the first such treatment known to date. "Prime editing," a technique more precise than the conventional CRISPR-Cas9 method, is being used to rewrite DNA in liver cells to repair the gene mutation that prevents the body from expelling excess copper, treating a rare disease called Wilson disease.US biotech company Prime Medicine announced that earlier this month it successfully treated the first participant, with initial results expected next year.
2026-10-30
For cryomedicine practitioners, the takeaway is this: cryopreservation is no longer just about keeping cells "alive" — it is being designed as a manufacturing step that shapes final therapeutic efficacy, which is precisely the key to whether "thaw-and-inject" can truly become reality.
2026-10-30
Life Biosciences, a US biotech company, has released the latest Phase 1 clinical trial data for its cellular reprogramming therapy ER-100 — the world's first age-reversal gene therapy trial. After the "rejuvenation" gene was injected into participants' eyes, the first three open-angle glaucoma patients all tolerated it well, and two have already shown early signs of vision improvement.
2026-10-23
Cryopreservation Breakthrough: Low-Dose Preconditioning Makes NK Cells "Fitter After Freezing"
The study forms a complete evidence chain from mechanistic dissection to intervention validation, indicating that cryopreservation is moving from an empirical craft toward precise design grounded in cell-death mechanisms. With optimization of cryoprotectant formulations, standardization of operating parameters and the development of novel preconditioning strategies, cryobiological technology will continue to provide solid support for immune cell therapy, cell bank construction and even regenerative medicine.
2026-10-23
No Fertilization Needed: A Clump of Cells Grew a Beating Heart on Its Own
The ethical boundary is just as clear: guidelines updated in 2025 by the International Society for Stem Cell Research prohibit implanting human stem-cell embryo models into human or animal uteri, and China's Ethical Guidelines for Human Organoid Research stipulate the same. As for when the first mouse will be born, Ding Sheng can give no timetable: "It is still a scientific question, not an engineering one."
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
